Orrù, S.; Pascariello, E.; Sotgiu, G.; Piras, D.; Saderi, L.; Muroni, M.R.; Carru, C.; Arru, C.; Mocci, C.; Pinna, G.;
et al. Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes. Biomedicines 2022, 10, 164.
https://doi.org/10.3390/biomedicines10010164
AMA Style
Orrù S, Pascariello E, Sotgiu G, Piras D, Saderi L, Muroni MR, Carru C, Arru C, Mocci C, Pinna G,
et al. Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes. Biomedicines. 2022; 10(1):164.
https://doi.org/10.3390/biomedicines10010164
Chicago/Turabian Style
Orrù, Sandra, Emanuele Pascariello, Giovanni Sotgiu, Daniela Piras, Laura Saderi, Maria Rosaria Muroni, Ciriaco Carru, Caterina Arru, Cristina Mocci, Giampietro Pinna,
and et al. 2022. "Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes" Biomedicines 10, no. 1: 164.
https://doi.org/10.3390/biomedicines10010164
APA Style
Orrù, S., Pascariello, E., Sotgiu, G., Piras, D., Saderi, L., Muroni, M. R., Carru, C., Arru, C., Mocci, C., Pinna, G., Barbara, R., Cossu-Rocca, P., & De Miglio, M. R.
(2022). Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes. Biomedicines, 10(1), 164.
https://doi.org/10.3390/biomedicines10010164